Abstract
Bone cancer pain is a complex process with many potential targets for therapeutic intervention. As pain is the most common presenting symptom in patients with skeletal metastases and is directly proportional to the patient’s quality of life, clinical advancements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels has shown significant clinical progress in the treatment of cancer-related bone pain. With continued efforts into these and other therapeutic strategies, we hope to continue to improve the quality of life of those patients suffering with bone cancer pain.
| Original language | English (US) |
|---|---|
| Title of host publication | Metastatic Bone Disease |
| Subtitle of host publication | An Integrated Approach to Patient Care |
| Publisher | Springer New York |
| Pages | 37-44 |
| Number of pages | 8 |
| ISBN (Electronic) | 9781461456629 |
| ISBN (Print) | 9781461456612 |
| DOIs | |
| State | Published - Jan 1 2015 |
Bibliographical note
Publisher Copyright:© Springer Science+Business Media New York 2016.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bisphosphonates
- Bone cancer
- Denosumab
- Ion channels
- Osteoclast
- Pain
- Skeletal metastasis
Fingerprint
Dive into the research topics of 'Biology of bone cancer pain'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS